NIH CA80098-S2 (Co-PI: McLennan)
07/01/2002 – 12/31/2010
ACRIN/National Lung Screening Trial (sub-contract from the American College of Radiology Imaging Network)
NIH 1 R01 HL64368 (PI: Hoffman, Co-PI: McLennan)
08/01/2005 – 07/30/2010
Image and model based analysis of lung disease (Bioengineering Research Partnership), Department of Health and Human Services
NIH R01 HL080184 (PI: Hoffman, Co-PI: McLennan)
08/01/2006 – 07/31/2011
Quantitative CT-based lung atlas of the mouse
NIH R01 HL079406 (PI: Reinhardt, Co-PI: McLennan)
04/01/2006 – 03/31/2011
Regional lung mechanics by 3D image registration
Asthmatx Inc (PI: McLennan)
03/01/2006 – 03/31/2012
Safety and effectiveness of the Alair System for the treatment of asthma: a multi-center randomized clinical trial.
NIH R01 HL079406 (PI: Reinhardt)
04/01/2006 – 03/31/2011
Regional lung mechanics by 3D imaging registration
Asthmatx Inc (PI: McLennan)
03/01/2006 – 03/31/2012
Safety and effectiveness of the Alair System for the treatment of asthma. A multicenter randomized clinical trial.
National Jewish 24021401 (PI: McLennan)
09/27/2007 – 07/31/2009
Genetic epidemiology of COPD – Sub-contract
NIH R01 CA129022 (PI: McLennan)
09/01/2007 – 07/31/2012
Precise correspondence of 3D pathology with radiological features in lung nodules.
Aeris Therapeutic 01-C06-003 (PI: McLennan)
07/10/2007 – 05/01/2010
Phase II study of the 20 ml biological lung volume reduction (BLVR) system in Pat Lobe predominant emphysema
Broncus Tech Inc (PI: McLennan)
01/23/2007 – 12/31/2012
A randomized, double-blind study to evaluate the safety and effectiveness of exhaled drug-eluting stent in homogeneous emphysema subjects with severe hyperinflation (EASE Study)
NIH P30PRO ES005606 (PI: Thorne, Core Director: McLennan)
04/01/2007 – 03/31/2012
Environmental health sciences research center
NIH PPG HL091842 (PI: Welsh PI), Core C Director: McLennan)
09/01/2008 – 07/31/2013
Airway physiology and pathphysiology in a porcine CF model
Aeris Therapeutics 01-C07-002 (PI: McLennan)
04/15/2008 – 12/01/2010
Phase II study of the 20 ml biologic lung volume reduction system (BLVR) in patients with homogenous upper lobe predominant emphysema.
CFF Research MCLENN07XXO (PI: McLennan)
01/01/2008 – 12/30/2009
Understanding Cystic Fibrosis through novel digital imaging strategies.
